2015
DOI: 10.5935/1806-0013.20150043
|View full text |Cite
|
Sign up to set email alerts
|

Chemotherapy-induced peripheral neuropathy: review for clinical practice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
9
0
11

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 16 publications
(22 citation statements)
references
References 40 publications
(50 reference statements)
2
9
0
11
Order By: Relevance
“…Essas classes de quimioterapia, pelos efeitos terapêuticos que possuem, embora causem efeitos adversos, como a NPIQ, dificilmente podem ser substituídas por outras classes sem que a eficácia terapêutica no controle e cura da doença não seja comprometida. A NPIQ é um efeito adverso SIMÃO et al, 2015).…”
Section: Resultsunclassified
“…Essas classes de quimioterapia, pelos efeitos terapêuticos que possuem, embora causem efeitos adversos, como a NPIQ, dificilmente podem ser substituídas por outras classes sem que a eficácia terapêutica no controle e cura da doença não seja comprometida. A NPIQ é um efeito adverso SIMÃO et al, 2015).…”
Section: Resultsunclassified
“…According to the International Association for the Study of Pain (IASP), neuropathic pain is “the pain caused by injury or disease of the somatosensory system”. It is present in 40% of cancer patients, and CIPN patients have a three-fold greater chance of developing neuropathic pain, a condition that is characteristic of CIPN 30 . This finding supports the importance of identifying some other objective measure of CIPN symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…This may accredited to the effect of chemotherapeutic agents that interfere with axonal transport, target the sensory cell bodies and nerve axons, and induce neuronal cell death. [28] In this respect studies by Cavaletti and Marmiroli, 2015; Dermitzakis, Kimiskidis & Lazaridis, 2016 and Boland, Sherry, and Polomano, 2017 [29][30][31] reported that, clinically, CIPN presents as deficits in sensory, motor, and autonomic function but sensory symptoms are far more common than motor or autonomic.…”
Section: Discussionmentioning
confidence: 99%